Post Market Clinical Follow-Up Study on the Performance and Safety of Lyoplant®
NCT ID: NCT05441618
Last Updated: 2025-01-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2024-04-02
2025-01-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of the Performance of LYoplant® ONlay for Duraplasty
NCT02678156
Post-market Evaluation of HEMOBLAST™ Bellows in Spine Surgery
NCT04471350
The Efficacy and Safety of Lyoplant® Onlay in Repairing Cerebral Dura Mater
NCT03951272
PMCF Study on the Safety and Performance of PROSPACE 3D / PROSPACE 3D OBLIQUE / TSPACE 3D
NCT04542577
Long-term Clinical Follow-up Analysis of Patients With Lumbar Disease.
NCT06933004
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lyoplant®
Lyoplant® is a pure collagen implant obtained from bovine pericardium. The membrane is used for the replacement and extension of connective tissue structures in neurosurgery.
Lyoplant®
replacement and extension of connective tissue structures in neurosurgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lyoplant®
replacement and extension of connective tissue structures in neurosurgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Use of investigational device according to Instructions for Use (IfU)
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aesculap AG
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Philipp E Krauss, Dr.
Role: PRINCIPAL_INVESTIGATOR
Universitätsklinikum Augsburg AöR
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universitätsklinikum Augsburg AöR
Augsburg, Bavaria, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AAG-O-H-2112
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.